ceos - 2/10 - Xconomy

Entry	Author	Date	Location
Report: Genzyme Chief Could Reap $221.2M in Sanofi Deal	Ryan McBride	03/08/11	Boston
New Crimson Hexagon CEO Looking to Expand Analytics Services to Mobile, Target Life Sciences and Financial Services Clients	Erin Kutz	02/28/11	Boston
Genzyme, After Months of Holding Out, Agrees to be Sold to Sanofi-Aventis for $20.1B	Ryan McBride	02/16/11	Boston
New CEO for Datawatch	Erin Kutz	02/15/11	Boston
Sepaton Replaces CEO	Erin Kutz	02/14/11	Boston
Stromedix Chief, After Reloading the Company Treasury, Sets Sight on Trial for Deadly Lung Disease	Ryan McBride	02/07/11	Boston
Boston-Power Hires New CEO; Founder Lampe-Onnerud Says She’s Excited By Move	Erin Kutz	02/03/11	Boston
Genocea Biosciences Names New CEO	Ryan McBride	02/01/11	Boston
Searching for Meaning in Google’s Leadership Changes	Wade Roush	01/20/11	San Francisco
ReCellular Chief Sees Future for Yesterday’s Electronics	Ryan McBride	01/14/11	Detroit
Alkermes Finds New Home For Inhaled Drug-Delivery Tech with Civitas Spinout	Ryan McBride	01/10/11	Boston
Follica Co-Founder and Team Find New Clues About Male Baldness	Ryan McBride	01/04/11	Boston
Relume Names Lipsey CEO	Ryan McBride	12/16/10	Detroit
SmartCells CEO Reflects on Strategy Leading to $500M Exit with Merck	Ryan McBride	12/03/10	Boston
$1M for ImThera Medical	Ryan McBride	11/19/10	San Diego
Alkermes CEO Leans on Internal Pipeline as Bydureon Hangs Out in the Penalty Box	Ryan McBride	11/15/10	Boston
Former Pfizer Exec Leaves CEO Post at Cellceutix	Ryan McBride	11/10/10	Boston
Biogen Idec Offering Jobs to Quarter of San Diego Workers, While Most Get Layoff Notices	Ryan McBride	11/03/10	Boston
Changing of the Guard: 10 New CEOs in New England Tech, Life Sciences, and Energy	Gregory T. Huang	11/02/10	Boston
Bay Area Biotech Startup at Odds with Dana-Farber and Novartis Over Cancer Drug Rights	Ryan McBride	10/28/10	Boston
Boston Scientific to Sell Neurovascular Unit to Stryker for $1.5B	Ryan McBride	10/28/10	Boston
Curaspan Undergoes Big Expansion as Demand for Patient-Transition Software Grows	Ryan McBride	10/26/10	Boston
Study Shows Startup Executive Pay on the Mend	Ryan McBride	10/20/10	National
Memento Gets $2M Debt Deal, New CEO	Ryan McBride	10/18/10	Boston
Helicos Names New CEO	Ryan McBride	10/14/10	Boston
Sonus Gets New CEO	Erin Kutz	10/12/10	Boston
Baron Named CAR Chairman	Ryan McBride	09/28/10	Detroit
Jumptap Gets New CEO	Erin Kutz	09/27/10	Boston
New CEO for Evergreen Solar	Erin Kutz	09/24/10	Boston
Genzyme Boss Henri Termeer Not Ready To Sell to Sanofi, Ride Into the Sunset, Sources Say	Ryan McBride	09/22/10	Boston
Page 2 of 4	« previous page · next page »

Entry

Author

Date

Location

Report: Genzyme Chief Could Reap $221.2M in Sanofi Deal

03/08/11

New Crimson Hexagon CEO Looking to Expand Analytics Services to Mobile, Target Life Sciences and Financial Services Clients

Erin Kutz

02/28/11

Boston

Genzyme, After Months of Holding Out, Agrees to be Sold to Sanofi-Aventis for $20.1B

Ryan McBride